Cargando…
COVID-19 in Africa: preexisting immunity and HIV
Autores principales: | Snyman, Jumari, Sanders, Eduard J., Ndung’u, Thumbi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567318/ https://www.ncbi.nlm.nih.gov/pubmed/34723854 http://dx.doi.org/10.1097/QAD.0000000000003079 |
Ejemplares similares
-
The KT Jeang retrovirology prize 2023: Thumbi Ndung’u
por: Ndung’u, Thumbi
Publicado: (2023) -
The potential of lactoferrin, ovotransferrin and lysozyme as antiviral and immune-modulating agents in COVID-19
por: Mann, Jaclyn Kelly, et al.
Publicado: (2020) -
Similar Antibody Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 in Individuals Living Without and With Human Immunodeficiency Virus on Antiretroviral Therapy During the First South African Infection Wave
por: Snyman, Jumari, et al.
Publicado: (2021) -
Severe COVID-19 and preexisting hypertension: a matter of age?
por: Yamazaki, Osamu, et al.
Publicado: (2022) -
Prevalence and seasonality of common viral respiratory pathogens, including Cytomegalovirus in children, between 0–5 years of age in KwaZulu-Natal, an HIV endemic province in South Africa
por: Famoroti, Temitayo, et al.
Publicado: (2018)